[HTML][HTML] PPAR agonists and metabolic syndrome: an established role?
M Botta, M Audano, A Sahebkar, CR Sirtori… - International journal of …, 2018 - mdpi.com
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
[引用][C] PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, C Sirtori… - International Journal of …, 2018 - cir.nii.ac.jp
PPAR Agonists and Metabolic Syndrome: An Established Role? | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[PDF][PDF] PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, CR Sirtori… - Int. J. Mol …, 2018 - pdfs.semanticscholar.org
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
[HTML][HTML] PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, CR Sirtori… - … Journal of Molecular …, 2018 - ncbi.nlm.nih.gov
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, C Sirtori… - INTERNATIONAL …, 2018 - air.unimi.it
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
[HTML][HTML] PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar… - PPARs in Cellular …, 2019 - books.google.com
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar… - International …, 2018 - search.ebscohost.com
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar… - International …, 2018 - pubmed.ncbi.nlm.nih.gov
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
[PDF][PDF] PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, CR Sirtori, N Mitro… - Int. J. Mol. Sci, 2018 - academia.edu
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
PPAR Agonists and Metabolic Syndrome: An Established Role?
M Botta, M Audano, A Sahebkar, CR Sirtori, N Mitro… - 2018 - agris.fao.org
Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated …
